Stuart A. Arbuckle

2018

In 2018, Stuart A. Arbuckle earned a total compensation of $5.3M as EVP & Chief Commercial Officer at Vertex Pharmaceuticals, a 22% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$824,175
Option Awards$1,136,785
Salary$721,923
Stock Awards$2,625,244
Other$38,965
Total$5,347,092

Arbuckle received $2.6M in stock awards, accounting for 49% of the total pay in 2018.

Arbuckle also received $824.2K in non-equity incentive plan, $1.1M in option awards, $721.9K in salary and $39K in other compensation.

Rankings

In 2018, Stuart A. Arbuckle's compensation ranked 1,836th out of 14,244 executives tracked by ExecPay. In other words, Arbuckle earned more than 87.1% of executives.

ClassificationRankingPercentile
All
1,836
out of 14,244
87th
Division
Manufacturing
652
out of 5,758
89th
Major group
Chemicals And Allied Products
215
out of 2,119
90th
Industry group
Drugs
168
out of 1,808
91st
Industry
Pharmaceutical Preparations
126
out of 1,382
91st

Pay ratio

Stuart A. Arbuckle's Pay$5,347,092
Median Employee's Pay$232,178
Pay Ratio

23

to 1

In 2018, the annual total compensation of Stuart A. Arbuckle was $5,347,092.

The annual total compensation of the median employee at Vertex Pharmaceuticals was $232,178.

The ratio of Stuart A. Arbuckle's pay to the pay of median employee was therefore 23 to one.

Source: SEC filing on April 26, 2019.

Arbuckle's colleagues

We found six more compensation records of executives who worked with Stuart A. Arbuckle at Vertex Pharmaceuticals in 2018.

2018

Jeffrey Leiden

Vertex Pharmaceuticals

Chief Executive Officer

2018

Jeffrey Chodakewitz

Vertex Pharmaceuticals

Chief Medical Officer

2018

Amit Sachdev

Vertex Pharmaceuticals

EVP & Chief Regulatory Officer

2018

Michael Parini

Vertex Pharmaceuticals

EVP & Chief Legal and Administrative Officer

2018

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2018

Thomas Graney

Vertex Pharmaceuticals

Chief Financial Officer

News

You may also like